Alpha Tau Medical
Develops Alpha DaRT, a localized alpha-radiation therapy for solid tumors.
$14.85
After-hours close+0.18 (+1.23%)
At close$14.67(−0.95%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 4.50%4.06M sharesInsiders 3.63%3.28M sharesOther 91.87%82.99M shares
Shares outstanding 90.33M · Float 61.99M · 68.6% free float
Institutions13F, as of Mar 31, 2026
57 holders · 4.06M shares · 19 new positions · 28 increased · 14 reduced · 2 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Hightower Advisors, LLC | 875.0K | 0.97% | +188.4K | May 5, 2026 |
| Aquamarine Financial (Cayman) Ltd | 721.5K | 0.80% | +721.5Knew | May 15, 2026 |
| Apella Capital, LLC | 382.3K | 0.42% | 0 | Apr 20, 2026 |
| Ark Investment Management LLC | 292.1K | 0.32% | +292.1Knew | May 12, 2026 |
| UBS Group AG | 286.7K | 0.32% | +266.0K | May 5, 2026 |
| Kovitz Investment Group Partners, LLC | 147.1K | 0.16% | −10.7K | May 13, 2026 |
| Mariner, LLC | 146.4K | 0.16% | +21.2K | May 13, 2026 |
| Daytona Street Capital LLC | 146.1K | 0.16% | −5.1K | Apr 10, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Oramed Pharmaceuticals Inc.incl. Oramed Ltd. | 19.99% | 14.11M | 13D | May 1, 2025 ↗ |
| Uzi Sofer | 15.80% | 13.70M | 13G | Jul 24, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Michael Avruch | director | 1.57M | 1.74% | Mar 18, 2026 |
| Uzi Sofer | director, officer: Chief Executive Officer | 1.25M | 1.38% | Mar 18, 2026 |
| S. Morry Blumenfeld | director | 155.8K | 0.17% | Mar 18, 2026 |
| David Mark Milch | director | 118.1K | 0.13% | Mar 18, 2026 |
| Raphi Levy | officer: Chief Financial Officer | 90.2K | 0.10% | Aug 25, 2026 |
| Alan Adler | director | 54.4K | 0.06% | Mar 18, 2026 |
| Ruth Alon | director | 29.4K | 0.03% | Mar 18, 2026 |
| Maya Netser | director | 3.1K | 0.00% | Mar 18, 2026 |
| Nadav Kidron | director | 3.0K | 0.00% | Mar 18, 2026 |
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 21, 2026 | Raphi Levyofficer: Chief Financial Officer | Sale | 2,871 | $15.00 | 90,180 |
| Aug 11, 2026 | Raphi Levyofficer: Chief Financial Officer | Sale | 17,730 | $14.00 | 90,180 |
| Jul 6, 2026 | Raphi Levyofficer: Chief Financial Officer | Sale | 2,270 | $14.00 | 90,180 |
| Jul 2, 2026 | Raphi Levyofficer: Chief Financial Officer | Sale | 17,873 | $13.00 | 90,180 |
| Jul 1, 2026 | Raphi Levyofficer: Chief Financial Officer | Sale | 2,127 | $13.02 | 90,180 |
| Jun 30, 2026 | Raphi Levyofficer: Chief Financial Officer | Sale | 20,000 | $12.00 | 90,180 |
| Jun 25, 2026 | Raphi Levyofficer: Chief Financial Officer | Sale · 2 lots | 20,000 | $11.00 | 110,180 |
| Jun 23, 2026 | Raphi Levyofficer: Chief Financial Officer | Sale · 2 lots | 17,500 | $9.55 | 130,180 |
| Jun 3, 2026 | Raphi Levyofficer: Chief Financial Officer | Sale · 2 lots | 32,500 | $10.83 | 147,680 |
CongressHouse and Senate disclosures
Not reported.